Company Information

Iris BioTechnologies Inc. (OTCPink: IRSB)

Iris BioTechnologies Inc. (OTCBB:IRSB) is a life sciences company that provides you and your physicians the information to choose the best medical treatment regimen before the treatment begins. Iris enables precision healthcare and this is the future of medicine. Iris analyses the totality of who you are by looking at a combination of many things including your nucleic acids such as DNA and RNA as well as proteins, family medical history, life style, and environmental exposure. Iris offers the best approach to cancer treatment through actionable integration of molecular profiling with clinical decision making, precision analysis of potential cancer recurrence and chemotherapy effectiveness, along with matching to targeted therapies and therapies in clinical trials. The Iris Nano-Biochip™ product pipeline includes: CancerChip™, PrenatalChip™, NeuroChip™ (Alzheimer’s and Parkinson diseases), MetabolicChip™ (Diabetes), CardioChip™, and Chips for veterinary, agricultural (e.g., biofuel development), environmental, and other applications. The Iris BioWindows™ artificial intelligence system provides big data and analysis for clinical applications, drug development, and stem cell research.

Company Information

Iris BioTechnologies Inc.
5201 Great America Parkway
Suite 320
Santa Clara, CA 95054

Investor Relations


Q3 2016 Quarterly Results

Recent News